{"id":"https://openalex.org/W2466938692","doi":"https://doi.org/10.1080/10428194.2016.1195497","title":"Associations of ofatumumab exposure and treatment outcomes in patients with untreated CLL receiving chemoimmunotherapy","display_name":"Associations of ofatumumab exposure and treatment outcomes in patients with untreated CLL receiving chemoimmunotherapy","publication_year":2016,"publication_date":"2016-07-07","ids":{"openalex":"https://openalex.org/W2466938692","doi":"https://doi.org/10.1080/10428194.2016.1195497","mag":"2466938692","pmid":"https://pubmed.ncbi.nlm.nih.gov/27389174","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7053426"},"language":"en","primary_location":{"id":"doi:10.1080/10428194.2016.1195497","doi":"https://doi.org/10.1080/10428194.2016.1195497","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10428194.2016.1195497","pdf_url":null,"source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & Lymphoma","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7053426","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023508449","display_name":"Roxanne C. Jewell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roxanne C. Jewell","raw_affiliation_strings":["Novartis Pharmaceuticals, Morrisville, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals, Morrisville, NC, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036828560","display_name":"Thomas J. Kipps","orcid":"https://orcid.org/0000-0002-0064-4549","observed_orcids":["https://orcid.org/0000-0002-0064-4549"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]},{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas J. Kipps","raw_affiliation_strings":["UCSD Moores Cancer Center, La Jolla, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCSD Moores Cancer Center, La Jolla, CA, USA","institution_ids":["https://openalex.org/I36258959","https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005029408","display_name":"Jan D\u00fcrig","orcid":"https://orcid.org/0000-0002-7672-3905","observed_orcids":["https://orcid.org/0000-0002-7672-3905"]},"institutions":[{"id":"https://openalex.org/I4210119759","display_name":"Essen University Hospital","ror":"https://ror.org/02na8dn90","country_code":"DE","type":"funder","lineage":["https://openalex.org/I4210119759"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Jan D\u00fcrig","raw_affiliation_strings":["Klinik f\u00fcr H\u00e4matologie, Universit\u00e4tsklinikum Essen, Essen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Klinik f\u00fcr H\u00e4matologie, Universit\u00e4tsklinikum Essen, Essen, Germany","institution_ids":["https://openalex.org/I4210119759"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075222101","display_name":"Laimonas Gri\u0161kevi\u010dius","orcid":"https://orcid.org/0000-0002-3731-1537","observed_orcids":["https://orcid.org/0000-0002-3731-1537"]},"institutions":[{"id":"https://openalex.org/I4210161607","display_name":"Vilnius University Hospital Santariskiu Klinikos","ror":"https://ror.org/0590pq693","country_code":"LT","type":"healthcare","lineage":["https://openalex.org/I4210161607"]}],"countries":["LT"],"is_corresponding":false,"raw_author_name":"Laimonas Griskevicius","raw_affiliation_strings":["Vilnius University Hospital Santariskiu Klinikos, Vilnius University, Vilnius, Lithuania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vilnius University Hospital Santariskiu Klinikos, Vilnius University, Vilnius, Lithuania","institution_ids":["https://openalex.org/I4210161607"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019866348","display_name":"Stephan Stilgenbauer","orcid":"https://orcid.org/0000-0002-6830-9296","observed_orcids":["https://orcid.org/0000-0002-6830-9296"]},"institutions":[{"id":"https://openalex.org/I196349391","display_name":"Universit\u00e4t Ulm","ror":"https://ror.org/032000t02","country_code":"DE","type":"education","lineage":["https://openalex.org/I196349391"]},{"id":"https://openalex.org/I4210155144","display_name":"University Hospital Ulm","ror":"https://ror.org/05emabm63","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210155144"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Stephan Stilgenbauer","raw_affiliation_strings":["Department of Internal Medicine III, Universit\u00e4tsklinikum Ulm, Ulm, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine III, Universit\u00e4tsklinikum Ulm, Ulm, Germany","institution_ids":["https://openalex.org/I196349391","https://openalex.org/I4210155144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090624182","display_name":"Luk\u00e1\u0161 Smolej","orcid":"https://orcid.org/0000-0002-4187-8595","observed_orcids":["https://orcid.org/0000-0002-4187-8595"]},"institutions":[{"id":"https://openalex.org/I4210137570","display_name":"University Hospital Hradec Kr\u00e1lov\u00e9","ror":"https://ror.org/04wckhb82","country_code":"CZ","type":"healthcare","lineage":["https://openalex.org/I4210137570"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"Luk\u00e1\u0161 Smolej","raw_affiliation_strings":["4th Department of Internal Medicine \u2013 Hematology, University Hospital and Faculty of Medicine, Hradec Kr\u00e1lov\u00e9, Czech Republic"],"raw_orcid":"https://orcid.org/0000-0002-4187-8595","affiliations":[{"raw_affiliation_string":"4th Department of Internal Medicine \u2013 Hematology, University Hospital and Faculty of Medicine, Hradec Kr\u00e1lov\u00e9, Czech Republic","institution_ids":["https://openalex.org/I4210137570"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054654885","display_name":"Ji\u0159\u0131\u0301 Mayer","orcid":"https://orcid.org/0000-0003-0567-9887","observed_orcids":["https://orcid.org/0000-0003-0567-9887"]},"institutions":[{"id":"https://openalex.org/I4210102302","display_name":"University Hospital Brno","ror":"https://ror.org/00qq1fp34","country_code":"CZ","type":"healthcare","lineage":["https://openalex.org/I4210102302"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"Ji\u0159\u00ed Mayer","raw_affiliation_strings":["Department of Internal Medicine/Hemato-Oncology, University Hospital Brno, Brno, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine/Hemato-Oncology, University Hospital Brno, Brno, Czech Republic","institution_ids":["https://openalex.org/I4210102302"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011863718","display_name":"Georg He\u00df","orcid":"https://orcid.org/0000-0002-9282-5688","observed_orcids":["https://orcid.org/0000-0002-9282-5688"]},"institutions":[{"id":"https://openalex.org/I197323543","display_name":"Johannes Gutenberg University Mainz","ror":"https://ror.org/023b0x485","country_code":"DE","type":"education","lineage":["https://openalex.org/I197323543"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Georg Hess","raw_affiliation_strings":["Johannes Gutenberg University, Mainz, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johannes Gutenberg University, Mainz, Germany","institution_ids":["https://openalex.org/I197323543"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066598802","display_name":"Francisco J. Hernandez\u2010Ilizaliturri","orcid":"https://orcid.org/0000-0001-8054-3539","observed_orcids":["https://orcid.org/0000-0001-8054-3539"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Francisco J. Hernandez-Ilizaliturri","raw_affiliation_strings":["Roswell Park Cancer Institute, Buffalo, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roswell Park Cancer Institute, Buffalo, NY, USA","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027071793","display_name":"Swaminathan P. Iyer","orcid":"https://orcid.org/0000-0002-1646-813X","observed_orcids":["https://orcid.org/0000-0002-1646-813X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Swaminathan Padmanabhan-Iyer","raw_affiliation_strings":["Cancer Therapy and Research Center, San Antonio, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Therapy and Research Center, San Antonio, TX, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Lei Fang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lei Fang","raw_affiliation_strings":["Pharstat Inc., Raleigh, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharstat Inc., Raleigh, NC, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052272902","display_name":"Nancy Goldstein","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nancy Goldstein","raw_affiliation_strings":["Novartis Pharmaceuticals, Morrisville, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals, Morrisville, NC, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008130173","display_name":"Michele M. Gorczyca","orcid":"https://orcid.org/0000-0002-4897-4141","observed_orcids":["https://orcid.org/0000-0002-4897-4141"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michele Gorczyca","raw_affiliation_strings":["GlaxoSmithKline, Collegeville, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Collegeville, PA, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112446960","display_name":"Ira V Gupta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ira Gupta","raw_affiliation_strings":["Novartis Pharmaceuticals, King of Prussia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals, King of Prussia, PA, USA","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021435946","display_name":"Steen Lisby","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163256","display_name":"Genmab (Denmark)","ror":"https://ror.org/057pe1087","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210163256"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Steen Lisby","raw_affiliation_strings":["Genmab, Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genmab, Copenhagen, Denmark","institution_ids":["https://openalex.org/I4210163256"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089428686","display_name":"William G. Wierda","orcid":"https://orcid.org/0000-0002-7357-270X","observed_orcids":["https://orcid.org/0000-0002-7357-270X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"William G. Wierda","raw_affiliation_strings":["MD Anderson Cancer Center, The University of Texas, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MD Anderson Cancer Center, The University of Texas, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":null,"display_name":"for the Hx-CD20-407 Study Investigators","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"for the Hx-CD20-407 Study Investigators","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":14,"corresponding_author_ids":["https://openalex.org/A5089428686"],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":0.2038,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.55759579,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"58","issue":"2","first_page":"348","last_page":"356"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ofatumumab","display_name":"ofatumumab","score":1.0},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9760000109672546},{"id":"https://openalex.org/keywords/chemoimmunotherapy","display_name":"chemoimmunotherapy","score":0.9480000138282776},{"id":"https://openalex.org/keywords/fludarabine-and-cyclophosphamide","display_name":"fludarabine and cyclophosphamide","score":0.9670000076293945},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.972000002861023},{"id":"https://openalex.org/keywords/drug-exposure","display_name":"drug exposure","score":0.6039999723434448},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.8999999761581421},{"id":"https://openalex.org/keywords/objective-response","display_name":"objective response","score":0.9089999794960022},{"id":"https://openalex.org/keywords/17p-deletion","display_name":"17p deletion","score":0.7549999952316284},{"id":"https://openalex.org/keywords/serum-thymidine-kinase","display_name":"serum thymidine kinase","score":0.9750000238418579}],"concepts":[{"id":"https://openalex.org/C2778714382","wikidata":"https://www.wikidata.org/wiki/Q410656","display_name":"Ofatumumab","level":4,"score":0.9571759700775146},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8068997859954834},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.7156402468681335},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6243760585784912},{"id":"https://openalex.org/C2780790343","wikidata":"https://www.wikidata.org/wiki/Q5090610","display_name":"Chemoimmunotherapy","level":4,"score":0.6063329577445984},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5994862914085388},{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.5619670748710632},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4788903295993805},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.45334410667419434},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.40001213550567627},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.37582460045814514},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.35091301798820496},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3202069401741028},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.19154053926467896},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.18842792510986328},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.07161235809326172},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002869","descriptor_name":"Chromosome Aberrations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1080/10428194.2016.1195497","doi":"https://doi.org/10.1080/10428194.2016.1195497","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10428194.2016.1195497","pdf_url":null,"source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & Lymphoma","raw_type":"journal-article"},{"id":"pmid:27389174","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27389174","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & lymphoma","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:pubmedcentral.nih.gov:7053426","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7053426","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Leuk Lymphoma","raw_type":"Text"},{"id":"pmh:oai:escholarship.org:ark:/13030/qt32j19420","doi":null,"is_oa":false,"landing_page_url":"https://escholarship.org/uc/item/32j19420","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Leukemia & Lymphoma, vol 58, iss 2","raw_type":"article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:7053426","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7053426","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Leuk Lymphoma","raw_type":"Text"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G8225889400","display_name":"Chronic Lymphocytic Leukemia Research Consortium","funder_award_id":"4p01ca081534-16","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G944802235","display_name":null,"funder_award_id":"P01-CA-081534","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320310388","display_name":"Novartis Pharmaceuticals Corporation","ror":"https://ror.org/028fhxy95"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W60865865","https://openalex.org/W142412262","https://openalex.org/W146673805","https://openalex.org/W152426348","https://openalex.org/W1505676752","https://openalex.org/W1533841403","https://openalex.org/W1680606411","https://openalex.org/W2020494888","https://openalex.org/W2020671967","https://openalex.org/W2032685816","https://openalex.org/W2039144093","https://openalex.org/W2079089580","https://openalex.org/W2114063509","https://openalex.org/W2120319857","https://openalex.org/W2122725450","https://openalex.org/W2124575836","https://openalex.org/W2126529136","https://openalex.org/W2129358485","https://openalex.org/W2140606816","https://openalex.org/W2140687115","https://openalex.org/W2141139539","https://openalex.org/W2158803162","https://openalex.org/W2169386895","https://openalex.org/W2323490326","https://openalex.org/W2979489592"],"related_works":["https://openalex.org/W2521573206","https://openalex.org/W2260958248","https://openalex.org/W2020671967","https://openalex.org/W2424784666","https://openalex.org/W2114063509","https://openalex.org/W1995988675","https://openalex.org/W4234617992","https://openalex.org/W2465824739","https://openalex.org/W2000540399","https://openalex.org/W185506919"],"abstract_inverted_index":{"Relationships":[0],"between":[1],"patient":[2],"characteristics,":[3],"ofatumumab":[4,17,38,104,145],"pharmacokinetics,":[5],"and":[6,20,53,86,92,139],"treatment":[7],"outcomes":[8],"were":[9,29,56,72,94,106,127],"investigated":[10],"in":[11,23],"this":[12],"phase":[13],"2":[14],"trial":[15],"of":[16,62,101,117],"plus":[18,43],"fludarabine":[19],"cyclophosphamide":[21],"(FC)":[22],"untreated":[24],"chronic":[25],"lymphocytic":[26],"leukemia.":[27],"Patients":[28],"randomized":[30],"1:1":[31],"to":[32],"receive":[33],"500":[34],"or":[35,134],"1000":[36],"mg":[37],"(Cycle":[39],"1;":[40],"300":[41],"mg)":[42],"FC":[44],"every":[45],"4":[46],"weeks":[47],"for":[48,74,81],"six":[49],"cycles.":[50],"Median":[51],"Cmax":[52,85],"Ctrough":[54,87],"values":[55,71,88],"similar":[57],"at":[58,89],"Cycle":[59],"1":[60],"regardless":[61],"the":[63,115],"ultimate":[64],"clinical":[65],"outcome.":[66],"At":[67],"later":[68],"doses,":[69],"these":[70],"higher":[73],"patients":[75],"with":[76,97,109,130],"complete":[77],"response":[78,112],"(CR)":[79],"than":[80,144],"other":[82],"patients.":[83],"Higher":[84],"Cycles":[90],"3":[91],"6":[93],"significantly":[95],"associated":[96,108,129],"an":[98,110],"increased":[99],"likelihood":[100],"CR,":[102],"whereas":[103],"pharmacokinetics":[105],"not":[107],"objective":[111],"(OR)":[113],"on":[114],"basis":[116],"univariate":[118],"analyses.":[119],"Multivariate":[120],"analyses":[121],"indicated":[122],"that":[123],"baseline":[124],"patient/disease":[125],"factors":[126],"predominantly":[128],"CR":[131],"(17p":[132],"status)":[133],"OR":[135],"(bulky":[136],"lymphadenopathy,":[137],"gender,":[138],"serum":[140],"thymidine":[141],"kinase),":[142],"rather":[143],"pharmacokinetics.":[146],"Trial":[147],"registration:":[148],"www.clinicaltrials.gov":[149],"(NCT00410163).":[150]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-07-22T00:00:00"}